Caplin Point Laboratories Limited is an international pharmaceutical company specializing in branded generic medicines, injectable products, active pharmaceutical ingredients (APIs), and ophthalmic formulations. Founded in 1990, the company has built a strong presence across Latin America, Africa, the United States, and other emerging markets. Caplin Point has established expertise in anti-infectives, pain management, cardiovascular, diabetes, and hospital products while expanding its sterile injectable portfolio through dedicated manufacturing facilities. The company’s vertically integrated operations support product development, manufacturing, and global commercialization under stringent international quality standards. Strategic investments in regulated markets, manufacturing expansion, and product innovation have strengthened Caplin Point’s competitive position globally. By focusing on affordable medicines, regulatory compliance, and customer partnerships, the company continues to expand its international footprint while improving healthcare accessibility for patients across diverse global markets.
NSE: CAPLIPOINT | BSE: 524742
Chennai, Tamil Nadu, India
~2,500 employees
